Harvard Management Company’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-20,788
| Closed | -$252K | – | 23 |
|
|
2023
Q2 | $252K | Hold |
20,788
| – | – | 0.02% | 33 |
|
|
2023
Q1 | $264K | Hold |
20,788
| – | – | 0.03% | 48 |
|
|
2022
Q4 | $131K | Hold |
20,788
| – | – | 0.02% | 46 |
|
|
2022
Q3 | $469K | Hold |
20,788
| – | – | 0.06% | 46 |
|
|
2022
Q2 | $399K | Hold |
20,788
| – | – | 0.05% | 45 |
|
|
2022
Q1 | $965K | Hold |
20,788
| – | – | 0.1% | 42 |
|
|
2021
Q4 | $1.47M | Hold |
20,788
| – | – | 0.14% | 41 |
|
|
2021
Q3 | $2.42M | Hold |
20,788
| – | – | 0.14% | 35 |
|
|
2021
Q2 | $3.25M | Hold |
20,788
| – | – | 0.19% | 31 |
|
|
2021
Q1 | $3.94M | Hold |
20,788
| – | – | 0.22% | 33 |
|
|
2020
Q4 | $2.61M | Hold |
20,788
| – | – | 0.14% | 26 |
|
|
2020
Q3 | $2.26M | Hold |
20,788
| – | – | 0.12% | 22 |
|
|
2020
Q2 | $2.5M | Hold |
20,788
| – | – | 0.21% | 18 |
|
|
2020
Q1 | $2.09M | Hold |
20,788
| – | – | 0.33% | 16 |
|
|
2019
Q4 | $5.04M | Hold |
20,788
| – | – | 0.53% | 16 |
|
|
2019
Q3 | $3.41M | Hold |
20,788
| – | – | 0.32% | 14 |
|
|
2019
Q2 | $4.91M | Hold |
20,788
| – | – | 1.21% | 13 |
|
|
2019
Q1 | $5.48M | Sell |
20,788
-4,923
| -19% | -$1.3M | 1.39% | 10 |
|
|
2018
Q4 | $2.35M | Buy |
25,711
+4,923
| +24% | +$449K | 0.49% | 14 |
|
|
2018
Q3 | $4M | Hold |
20,788
| – | – | 1.02% | 17 |
|
|
2018
Q2 | $4.49M | Buy |
+20,788
| New | +$4.49M | 1.06% | 14 |
|